80 likes | 358 Views
UNITAID. Levies on airline tickets Innovative financing and solutions Dr Jorge Bermudez Executive Secretary, UNITAID www.unitaid.eu Brussels, 10 June 2010 EC Global Health Conference. What is UNITAID?. UNITAID Can globalization work for the poor?
E N D
UNITAID Levies on airline tickets Innovative financing and solutions Dr Jorge Bermudez Executive Secretary, UNITAID www.unitaid.eu Brussels, 10 June 2010 EC Global Health Conference
What is UNITAID? • UNITAID • Can globalization work for the poor? • UNITAID is an innovative financing mechanism that uses market-based tools to expand access to quality life-saving treatments for HIV/AIDS, TB and Malaria • Leverage price reductions of quality drugs and diagnostics • Accelerate availability Partners Working towards the common goal of expanding access to health
What we do • UNITAID is the first example of a global health agency to pursue public health outcomes through market impact by: • ensuring continuous supply of much needed medicines • stimulating higher volumes of production by guaranteeing a market for pharmaceutical manufacturers • promoting competition among producers; thereby • lowering prices of quality health commodities • introducing new FDCs • More than one billion dollars disbursed over a period of three years • UNITAID has supplied 21 million treatments for HIV/AIDS, malaria and TB to 94 countries worldwide, many of them in Africa HIV / AIDS 51 countries Malaria 29 countries Tuberculosis 72 countries
Innovative Financing • 70% of UNITAID's funds comes from a small levy on airline tickets in six countries • One of the first examples of a government-imposed solidarity tax for global health • Supported by 29 countries and the Gates Foundation • 5 further countries in the final stages of negotiation and to join shortly
Examples of UNITAID Actions and Impact • Supported 3 out of 4 children on treatment for HIV/AIDS through its funding and partnership with the Clinton Health Access Initiative. • Reduced prices by an average of 64% for leading paediatric AIDS regimens and by 43% for leading adult second-line AIDS regimens. • Committed US$ 130 million to the Global Fund's AMFm (Affordable Medicines Facility for Malaria) to make available affordable and highly-effective artemisinin-based combination therapy. • Invested US$ 54.5 million in the WHO’s Prequalification of Medicines Programme, which has helped make available 29 new and better adapted medicines, including new fixed-dose combinations and paediatric formulations. • Established a Medicines Patent Pool for AIDS medicines.
A great challenge ahead: First-line Second-line Possible third-line Source: Medecins sans Frontieres (www.msfaccess.org)
Take the plunge! Will the patent pool work? Yes, if: • Patent owners and generic manufacturers collaborate • Global Health Funding remains of sufficient levels to ensure the market • Political Support remains strong and because: • No one can absorb the human and financial cost of failure